ORBIMED ADVISORS LLC

Contact Information ORBIMED ADVISORS LLC
601 LEXINGTON AVENUE
NEW YORK NY  10022
Business Phone: (212) 739-6400
13F Investments by Sector - 09/30/2011
Investments by Sector Chart
13F Activity for 09/30/2011
[1]Market Value:
$2,693,953
New Purchases:
18 stocks
Additional Purchases:
37 stocks
Sold out of:
13 stocks
Reduced holdings in:
26 stocks
[1] - Market Value shown here may differ from what was reported on the actual 13F filing. The market value shown here includes only those securities that the Whalewisdom parsing engine successfully extracted. Value may also be rounded. Please refer to the actual 13F filing for verification.
Top 13F Holdings on 09/30/2011
Stock% of Portfolio
Pfizer Inc. 5.41%
WellPoint Inc. 4.74%
Allergan Inc. 4.55%
Bristol-Myers Squibb Company 4.17%
Gilead Sciences Inc. 3.69%
View All Holdings
Recent SEC Filings
Schedule 13D/G Summary There have been 2 Schedule 13D/G filing(s) received since 09/30/2011